Publications by authors named "Tom J Keeley"

Article Synopsis
  • Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are new oral treatments for anemia in chronic kidney disease (CKD) that were compared in a study of dialysis and non-dialysis patients using network meta-analyses.* -
  • The study looked at three main outcomes: changes in hemoglobin levels, the risk of major cardiovascular events, and quality of life through a health survey, analyzing data from seventeen phase III trials involving nearly 8,000 patients.* -
  • The results indicated no significant differences in hemoglobin changes or cardiovascular risk among the three HIF-PHIs, but daprodustat showed a greater improvement in quality of life compared to roxad
View Article and Find Full Text PDF